{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T06:34:28Z","timestamp":1762065268482,"version":"build-2065373602"},"reference-count":24,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"ST Associazione Sclerosi Tuberosa"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cutaneous lesions are one of the hallmarks of tuberous sclerosis complex (TSC), a genetic disease in which mTOR is hyperactivated due to the lack of hamartin or tuberin. To date, novel pharmacological treatments for TSC cutaneous lesions that are benign but still have an impact on a patient\u2019s life are needed, because neither surgery nor rapamycin administration prevents their recurrence. Here, we demonstrated that primary TSC2-\/meth cells that do not express tuberin for an epigenetic event caused cutaneous lesions and follicular neogenesis when they were subcutaneously injected in nude mice. Tuberin-null cells localized in the hair bulbs and alongside mature hairs, where high phosphorylation of S6 and Erk indicated mTOR hyperactivation. Interestingly, 5-azacytidine treatment reduced hair follicles, indicating that chromatin remodeling agents might be effective on TSC lesions in which cells lack tuberin for an epigenetic event. Moreover, we demonstrated that the primary TSC2-\/meth cells had metastatic capability: when subcutaneously injected, they reached the bloodstream and lymphatics and invaded the lungs, causing the enlargement of the alveolar walls. The capability of TSC2-\/meth cells to survive and migrate in vivo makes our mouse model ideal to follow the progression of the disease and test potential pharmacological treatments in a time-dependent manner.<\/jats:p>","DOI":"10.3390\/ijms23179713","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T01:39:19Z","timestamp":1661737159000},"page":"9713","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Primary TSC2-\/meth Cells Induce Follicular Neogenesis in an Innovative TSC Mouse Model"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3813-9038","authenticated-orcid":false,"given":"Clara","family":"Bernardelli","sequence":"first","affiliation":[{"name":"Laboratory of Pharmacology, Department of Health Sciences, Universit\u00e0 degli Studi di Milano, 20142 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eloisa","family":"Chiaramonte","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology, Department of Health Sciences, Universit\u00e0 degli Studi di Milano, 20142 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1999-129X","authenticated-orcid":false,"given":"Silvia","family":"Ancona","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology, Department of Health Sciences, Universit\u00e0 degli Studi di Milano, 20142 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6106-3721","authenticated-orcid":false,"given":"Silvia M.","family":"Sirchia","sequence":"additional","affiliation":[{"name":"Medical Genetics, Department of Health Sciences, Universit\u00e0 degli Studi di Milano, 20142 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amilcare","family":"Cerri","sequence":"additional","affiliation":[{"name":"Dermatology Unit, Department of Health Sciences, Universit\u00e0 degli Studi di Milano, 20142 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9096-713X","authenticated-orcid":false,"given":"Elena","family":"Lesma","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology, Department of Health Sciences, Universit\u00e0 degli Studi di Milano, 20142 Milan, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/B978-0-444-64076-5.00052-1","article-title":"Tuberous Sclerosis Complex","volume":"148","author":"Hasbani","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR Signaling in Growth Control and Disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"16035","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous Sclerosis Complex","volume":"2","author":"Henske","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2021.07.011","article-title":"International Tuberous Sclerosis Complex Consensus Group. Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations","volume":"123","author":"Northrup","year":"2021","journal-title":"Pediatr. Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3390\/dermatopathology8030029","article-title":"Histological Patterns of Skin Lesions in Tuberous Sclerosis Complex: A Panorama","volume":"8","author":"Cascarino","year":"2021","journal-title":"Dermatopathology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"121","DOI":"10.2165\/11634580-000000000-00000","article-title":"Topical rapamycin therapy to alleviate the cutaneous manifestations of tuberous sclerosis complex: A double-blind, randomized, controlled trial to evaluate the safety and efficacy of topically applied rapamycin","volume":"12","author":"Koenig","year":"2012","journal-title":"Drugs R D"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.2353\/ajpath.2009.080799","article-title":"The Methylation of the TSC2 Promoter Underlies the Abnormal Growth of TSC2 Angiomyolipoma-Derived Smooth Muscle Cells","volume":"174","author":"Lesma","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/00000478-199311000-00002","article-title":"Transbronchial Biopsy in Lymphangiomyomatosis of the Lung HMB45 for Diagnosis","volume":"17","author":"Bonetti","year":"1993","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1038\/s41467-020-16978-z","article-title":"mTOR and S6K1 Drive Polycystic Kidney by the Control of Afadin-Dependent Oriented Cell Division","volume":"11","author":"Bonucci","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.ajpath.2012.05.017","article-title":"Development of a lymphangioleiomyomatosis model by endonasal administration of human TSC2\u2212\/\u2212 smooth muscle cells in mice","volume":"181","author":"Lesma","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3816\/CLC.2010.n.052","article-title":"Intratracheally administered 5-azacytidine is effective against orthotopic human lung cancer xenograft models and devoid of important systemic toxicity","volume":"11","author":"Mahesh","year":"2010","journal-title":"Clin. Lung Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"315240","DOI":"10.1155\/2015\/315240","article-title":"Anti-EGFR Antibody Reduces Lung Nodules by Inhibition of EGFR-Pathway in a Model of Lymphangioleiomyomatosis","volume":"2015","author":"Lesma","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ncomms1236","article-title":"Human TSC2-Null Fibroblast-like Cells Induce Hair Follicle Neogenesis and Hamartoma Morphogenesis","volume":"2","author":"Li","year":"2011","journal-title":"Nat. Commun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1056\/NEJM199903043400905","article-title":"Mosaicism in tuberous sclerosis as a potential cause of the failure of molecular diagnosis","volume":"340","author":"Kwiatkowska","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Guo, Y., Dreier, J.R., Cao, J., Du, H., Granter, S.R., and Kwiatkowski, D.J. (2016). Analysis of a Mouse Skin Model of Tuberous Sclerosis Complex. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0167384"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"13571","DOI":"10.1073\/pnas.202476899","article-title":"Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signalling","volume":"99","author":"Tee","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/cup.13411","article-title":"Differential Expression of Phospho-S6 in Hair Follicle Tumors: Evidence of Mammalian Target of Rapamycin Pathway Activation","volume":"46","author":"Luis","year":"2019","journal-title":"J. Cutan. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"7106","DOI":"10.1158\/0008-5472.CAN-06-4798","article-title":"Identification of S664 TSC2 Phosphorylation as a Marker for Extracellular Signal-Regulated Kinase\u2013Mediated mTOR Activation in Tuberous Sclerosis and Human Cancer","volume":"67","author":"Ma","year":"2007","journal-title":"Cancer Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1073\/pnas.0712397105","article-title":"Mesenchymal-Epithelial Interactions Involving Epiregulin in Tuberous Sclerosis Complex Hamartomas","volume":"105","author":"Li","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1038\/onc.2015.358","article-title":"Exosomes Mediate the Acquisition of the Disease Phenotypes by Cells with Normal Genome in Tuberous Sclerosis Complex","volume":"35","author":"Patel","year":"2016","journal-title":"Oncogene"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ccm.2016.04.002","article-title":"Lymphangioleiomyomatosis","volume":"37","author":"Johnson","year":"2016","journal-title":"Clin. Chest Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Bernardelli, C., Ancona, S., Lazzari, M., Lettieri, A., Selvaggio, P., Massa, V., Gervasini, C., Di Marco, F., Chiaramonte, R., and Lesma, E. (2022). LAM Cells as Potential Drivers of Senescence in Lymphangioleiomyomatosis Microenvironment. Int. J. Mol. Sci., 13.","DOI":"10.3390\/ijms23137040"},{"key":"ref_23","first-page":"1653","article-title":"A demethylating agent enhances chemosensitivity to vinblastine in a xenograft model of renal cell carcinoma","volume":"38","author":"Iwata","year":"2011","journal-title":"Int. J. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Ancona, S., Orpianesi, E., Bernardelli, C., Chiaramonte, E., Chiaramonte, R., Terraneo, S., Di Marco, F., and Lesma, E. (2021). Differential Modulation of Matrix Metalloproteinases-2 and -7 in LAM\/TSC Cells. Biomedicines, 9.","DOI":"10.3390\/biomedicines9121760"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/17\/9713\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:16:09Z","timestamp":1760141769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/17\/9713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":24,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["ijms23179713"],"URL":"https:\/\/doi.org\/10.3390\/ijms23179713","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2022,8,26]]}}}